Ermenegildo Zegna N.V. ZGN 深 沪
等待开盘 11-24 09:30:00 美东时间
10.22
+0.380
+3.86%
华盛通- 最 高10.35
- 今 开9.94
- 成交量 54.46万股
- 最 低 9.94
- 昨 收 9.84
- 总市值 25.96亿
- 52周最高 10.70
- 市盈率 静 31.16
- 换手率 0.21%
- 52周最低 5.9085
- 委 比 31.87%
- 总股本 2.54亿
- 历史最高 16.0896
- 量 比 1.32
- 振 幅 4.17%
- 历史最低 5.9085
- 每 手 1
- 风险率 0.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ermenegildo Zegna N.V. announces key management changes
Ermenegildo Zegna N.V. (ZGN) announced a new leadership structure for the Group and ZEGNA brand, effective January 1, 2026. Gianluca Tagliabue, currently Group CFO and COO, will assume the role of Gr...
今天 19:38
Ermenegildo Zegna Appoints Ermenegildo "Gildo" Zegna As Group Executive Chairman; Gianluca Tagliabue To Assume Group CEO Role
Ermenegildo Zegna N.V. (NYSE:ZGN) (the "Company" and, together with its consolidated subsidiaries, the "Ermenegildo Zegna Group" or the "Group") today announced a new leadership structure for the Group and ZEGNA brand,
今天 19:34
Ermenegildo Zegna reports Q3 results
Ermenegildo Zegna press release (NYSE:ZGN): Q3 Revenue of €398.2M. More on Ermenegildo Zegna Ermenegildo Zegna N.V. (ZGN) Q3 2025 Sales Call Transcript Ermenegildo Zegna N.V. (ZGN) Q2 2025 Earnings Ca...
10-24 02:30
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
10-15 18:20
Jefferies Initiates Coverage On Ermenegildo Zegna with Buy Rating, Announces Price Target of $12.9
Jefferies analyst Bhumi Kanabar initiates coverage on Ermenegildo Zegna (NYSE:ZGN) with a Buy rating and announces Price Target of $12.9.
10-14 18:49
Ermenegildo Zegna to Announce Q3 2025 Revenues
Ermenegildo Zegna ( ($ZGN) ) has shared an announcement. On October 9, 2025, Er...
10-09 18:57
A Look Into Ermenegildo Zegna Inc's Price Over Earnings
In the current session, the stock is trading at $10.14, after a 5.30% increase....
10-03 06:00
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
B of A Securities Maintains Buy on Ermenegildo Zegna, Raises Price Target to $10
B of A Securities analyst Daria Nasledysheva maintains Ermenegildo Zegna (NYSE:ZGN) with a Buy and raises the price target from $9.5 to $10.
09-23 20:33
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
